5 reports

Technology Review - Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/ microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing. - Revie

  • Medical Biotechnology
  • Monoclonal Antibody
  • Switzerland
  • Forecast
  • Market Size

Technology Review - Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/ microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing. - Revie

  • Medical Biotechnology
  • Monoclonal Antibody
  • Norway
  • Forecast
  • Market Size
  • PARTNERSHIPS
  • VENTURE FINANCING

The additional unpaid payments may, however, be accelerated by either party at any time after ## July 2019.

  • Monoclonal Antibody
  • Pharmaceutical
  • Switzerland
  • Company
  • Novimmune SA

Europe' s first biosimilar monoclonal antibody – Celltrion and Hospira' s biosimilar Remicade product Inflectra/ Remsima – is approaching its second year anniversary, following approval in the second half of 2013.

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • Norway
  • Forecast

Other Developmental Activities Product Description Monoclonal Antibody for Oncology and Inflammation Monoclonal antibody is under development for the treatment of cancer and inflammation.

  • Monoclonal Antibody
  • Therapy
  • Switzerland
  • Company Operations
  • Delenex Therapeutics AG